Clinical trials in Dendermonde

Innovative research focusing on lipoprotein reduction and prevention of major cardiovascular events in patients with established CVD. Studies evaluating new therapeutic approaches for reducing cardiovascular risks.

• Atherosclerotic cardiovascular disease prevention
• Lipid management therapies
• Cardiovascular risk reduction

Cutting-edge trials examining novel compounds for improving cardiovascular outcomes.

Studies investigating treatments for atrial fibrillation and stroke prevention. Research comparing new anticoagulation therapies with established treatments for preventing systemic embolism.

• Stroke prevention in AF
• Novel anticoagulants
• Cardioembolic event prevention

Advanced clinical research focusing on improving outcomes in cardiac rhythm management.

Research targeting rare cardiac conditions including transthyretin amyloidosis with cardiomyopathy. Evaluation of innovative treatments for specific cardiac pathologies.

• Cardiomyopathy management
• Rare cardiac diseases
• Targeted therapeutic approaches

Focused studies on improving survival rates and quality of life in specialized cardiac conditions.

Clinical trials examining treatments for acute ischemic stroke and high-risk transient ischemic attacks. Studies evaluating new therapeutic options for stroke prevention and management.

• Post-stroke care
• TIA management
• Stroke prevention strategies

Development of advanced treatments for better stroke outcomes.

Studies investigating the role of acetylsalicylic acid in improving survival rates for colon cancer patients. Research focused on preventing cancer recurrence after surgical intervention.

• Colon cancer treatment
• Post-surgical care
• Cancer recurrence prevention

Innovative approaches in cancer survival improvement strategies.